23-24th September | Amsterdam RAI, Halls 2 & 3
Europe’s leading congress on drug and patient safety, convening C-suite, R&D, and data leaders to shape the future of pharmacovigilance, benefit-risk management, and the role of AI in transforming safety monitoring.
Find us at Booth #200 across both days.
Meet our speakers
Jason Bryant
SVP, Product Management, AI – ArisGlobal
- 23 September 2026 | 12:20pm
Can You Trust Agentic AI? Governing the Next Era of Pharmacovigilance
As pharmacovigilance moves toward Agentic AI, the conversation is shifting from automation to trust. The challenge is no longer just validating outputs, but governing how AI systems reason, orchestrate workflows, and support decisions within regulated environments. This session explores how organizations can operationalize AI responsibly through transparency, governance, measurable performance, and human oversight. Using real-world examples, we will discuss how concepts such as provenance, inspectability, and behavioural assurance help enable trusted AI in safety operations. Learn how bounded autonomy can accelerate signal detection, case intake, and regulatory decision support while maintaining compliance, accountability, and human control.
Lucinda Smith
Chief Safety Product Officer – ArisGlobal
- 23 September 2026 | 2:40pm
From Potential to Trusted Adoption: Scaling Agentic AI in Pharmacovigilance
As AI becomes increasingly embedded across pharmacovigilance, the conversation is shifting from experimentation to trust and operational adoption. In this panel discussion, PV leaders from leading pharmaceutical organizations will share how they are building confidence in AI within regulated environments and what it will take to move beyond 100% manual review of AI-generated outputs. The discussion will explore governance, validation, performance monitoring, and human oversight, as well as the practical challenges of scaling AI while maintaining compliance, quality, and accountability.
